AAAAAA
Results: 51-70/70
Authors:
LUDESCHER C
HILBE W
EISTERER W
PREUSS E
HOFMANN J
THALER J
Citation: C. Ludescher et al., FLOW CYTOMETRIC DETERMINATION OF ACTIVITY OF P-GLYCOPROTEIN IN TUMOR SAMPLES, Wiener Klinische Wochenschrift, 106(8), 1994, pp. 242-246
Authors:
NACHBAUR D
SCHWAIGHOFER H
THALER J
WEYRER W
FINK M
NUSSBAUMER W
FRITSCH E
NIEDERWIESER D
Citation: D. Nachbaur et al., RESULTS OF BONE-MARROW TRANSPLANTATION FO R HEMATOLOGIC MALIGNANCIES AND SOLID TUMORS IN INNSBRUCK, Wiener Klinische Wochenschrift, 106(7), 1994, pp. 201-207
Authors:
NACHBAUR D
SCHWAIGHOFER H
PETERSEN F
THALER J
NUSSBAUMER W
FEND F
NIEDERWIESER D
Citation: D. Nachbaur et al., SUCCESSFUL 2ND TRANSPLANT FROM AN HLA-IDENTICAL UNRELATED DONOR AFTERGRAFT-REJECTION IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA, Transplantation, 57(3), 1994, pp. 478-480
Authors:
HILBE W
EISTERER W
SCHMID C
STARZ I
SILLY H
DUBA C
LUDESCHER C
THALER J
Citation: W. Hilbe et al., BONE-MARROW LYMPHOCYTE SUBSETS IN MYELODYSPLASTIC SYNDROMES, Journal of Clinical Pathology, 47(6), 1994, pp. 505-507
Authors:
UTZ I
HOFER S
REGENASS U
HILBE W
THALER J
GRUNICKE H
HOFMANN J
Citation: I. Utz et al., THE PROTEIN-KINASE-C IN CGP-41251, A STAUROSPORINE DERIVATIVE WITH ANTITUMOR-ACTIVITY, REVERSES MULTIDRUG-RESISTANCE, International journal of cancer, 57(1), 1994, pp. 104-110
Authors:
RITTER M
HUBER C
AUBOCK J
POHLMARKL H
TROPPMAIR J
HEROLD M
GACHTER A
NUSSBAUMER W
BOCK G
NACHBAUR D
WESTHOFF U
EIBL B
SCHWAIGHOFER H
THALER J
GROSSEWILDE H
NIEDERWIESER D
Citation: M. Ritter et al., LYTIC SUSCEPTIBILITY OF TARGET-CELLS TO CYTOTOXIC T-CELLS IS DETERMINED BY THEIR CONSTITUTIVE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ANTIGEN EXPRESSION AND CYTOKINE-INDUCED ACTIVATION STATUS, Immunology, 81(4), 1994, pp. 569-577
Authors:
ZITTOUN R
MANDELLI F
DEWITTE T
WILLEMZE R
THALER J
HAYAT M
STRYCKMANS P
PEETERMANS M
DARDENNE M
SOLBU G
SUCIU S
Citation: R. Zittoun et al., RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) DURING INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A RANDOMIZED TRIAL FROM EORTC-GIMEMA LEUKEMIA COOPERATIVE GROUPS, Blood, 84(10), 1994, pp. 10000231-10000231
Authors:
FEND F
GSCHWENDTNER A
GREDLER E
THALER J
DIETZE O
Citation: F. Fend et al., DETECTION OF MONOCLONAL B-CELL POPULATIONS IN DECALCIFIED, PLASTIC-EMBEDDED BONE-MARROW BIOPSIES WITH THE POLYMERASE CHAIN-REACTION, American journal of clinical pathology, 102(6), 1994, pp. 850-855
Authors:
EISTERER W
HILBE W
LUDESCHER C
THALER J
Citation: W. Eisterer et al., CONTRIBUTION OF DRC-1 AND LEU-M5 TO DIFFERENTIAL-DIAGNOSIS IN B-CELL LYMPHOMAS, Acta haematologica, 91(2), 1994, pp. 114-114
Authors:
LUDESCHER C
HILBE W
EISTERER W
PREUSS E
HUBER C
GOTWALD M
HOFMANN J
THALER J
Citation: C. Ludescher et al., ACTIVITY OF P-GLYCOPROTEIN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA DETERMINED BY A FLOW CYTOMETRIC ASSAY, Journal of the National Cancer Institute, 85(21), 1993, pp. 1751-1758
Authors:
THALER J
Citation: J. Thaler, INTERFERON-ALPHA FOR THE TREATMENT OF CHR ONIC MYELOGENOUS LEUKEMIA, Acta medica austriaca, 20(3), 1993, pp. 65-69
Authors:
SCHIRMER M
VOGEL W
THALER J
UMLAUFT F
ZILIAN U
GEISEN F
KONWALINKA G
Citation: M. Schirmer et al., SUBFULMINANT HEPATITIS-C IN A PATIENT WITH HAIRY-CELL LEUKEMIA DURINGTREATMENT WITH CLADRIBINE, Experimental hematology, 21(8), 1993, pp. 1091-1091
Authors:
THALER J
FLUCKINGER T
HUBER H
LANG A
ABBREDERIS C
SEEWANN H
SILLY H
BALDINGER C
DUBA C
HUBER C
NIEDERWIESER D
Citation: J. Thaler et al., TREATMENT OF 11 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA-2C AND LOW-DOSE CYTOSINE-ARABINOSIDE, Leukemia research, 17(8), 1993, pp. 711-715
Authors:
THALER J
GASTL G
FLUCKINGER T
NIEDERWIESER D
HUBER H
SEEWANN H
SILLY H
LANG A
ABBREDERIS C
GADNER H
FEREBERGER W
SCHILLER L
KOCK L
FRIDRIK M
DUBA C
FALK M
BERGER M
KUHR T
HUBER C
Citation: J. Thaler et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALFA-2C - RESPONSE RATE AND TOXICITY IN A PHASE-II MULTICENTER STUDY, Seminars in hematology, 30(3), 1993, pp. 17-19
Authors:
NIEDERWIESER D
ARCESE W
BANDINI G
SCHWAIGHOFER H
THALER J
BOSI A
DIBARTOLOMEO P
ALESSANDRINO EP
URBAN C
GRATWOHL A
Citation: D. Niederwieser et al., PROPHYLACTIC USE OF INTERFERON-ALFA AFTER BONE-MARROW TRANSPLANTATIONFOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA AT HIGH-RISK OF RELAPSE - A PILOT-STUDY, Seminars in hematology, 30(3), 1993, pp. 40-43
Authors:
EISTERER W
HILBE W
LUDESCHER C
FEND F
THALER J
Citation: W. Eisterer et al., DIAGNOSTIC-VALUE OF IMMUNOPHENOTYPING IN LOW-GRADE B-CELL LYMPHOMA, British Journal of Haematology, 85(1), 1993, pp. 236-237
Authors:
THALER J
GRUNEWALD K
GATTRINGER C
HO AD
WEYRER K
DIETZE O
STAUDER R
FLUCKINGER T
LANG A
HUBER H
Citation: J. Thaler et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED WITHPENTOSTATIN - LYMPHOCYTE SUBPOPULATIONS AND RESIDUAL BONE-MARROW INFILTRATION, British Journal of Haematology, 84(1), 1993, pp. 75-82
Authors:
LUDESCHER C
HILBE W
EISTERER W
THALER J
GOTWALD M
HOFMANN J
Citation: C. Ludescher et al., LOW INCIDENCE OF ACTIVITY OF P-GLYCOPROTEIN (P-170) IN DE-NOVO ACUTE LYMPHOBLASTIC-LEUKEMIA DETERMINED BY A FLOW CYTOMETRIC ASSAY, Blood, 82(11), 1993, pp. 3505-3506
ADHESION TO HIGH ENDOTHELIAL VENULES - A MODEL FOR DISSEMINATION MECHANISMS IN NON-HODGKINS-LYMPHOMA
Authors:
STAUDER R
HAMADER S
FASCHING B
KEMMLER G
THALER J
HUBER H
Citation: R. Stauder et al., ADHESION TO HIGH ENDOTHELIAL VENULES - A MODEL FOR DISSEMINATION MECHANISMS IN NON-HODGKINS-LYMPHOMA, Blood, 82(1), 1993, pp. 262-267
Authors:
PRIOR C
LUDESCHER C
OTT G
SPITERI MA
ROTONDETTO S
THALER J
Citation: C. Prior et al., DIFFERENCES IN MONOKINE RECEPTOR EXPRESSION BETWEEN BRONCHOALVEOLAR AND BLOOD MONONUCLEAR-CELLS, The American review of respiratory disease, 147(4), 1993, pp. 276-276